Getting to the Heart of Prostate Cancer: Explaining Options to Improve Outcomes for Men of Color- March 11, 2022

Claiming Credit for Session

Thank you for attending Getting to the Heart of Prostate Cancer: Explaining Options to Improve Outcomes for Men of Color on March 11, 2022. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to take an evaluation to claim your credit on the following page.

Target Audience

Urologists, medical oncologists, oncology NP/PAs, pharmacists, nurses, and other HCPs responsible for treatment decisions for patients with prostate cancer

Learning Objectives

At the completion of this activity, pharmacists will be able to:

  • Delineate clinical differences between GnRH agonists and antagonists used in different stages of prostate cancer
  • Describe health disparities for Black men with prostate cancer and understand the prevalence of prostate cancer amongst Black men
  • Assess the cardiovascular risk associated with androgen deprivation therapy in patients with metastatic prostate cancer
  • Integrate a multidisciplinary approach into treatment decisions for patients initiating ADT and novel antiandrogens for prostate cancer
Course summary
Available credit: 
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
    Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 ANCC
    Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
  • 1.00 Participation
Course opens: 
03/11/2022
Course expires: 
03/11/2023
Rating: 
0

Speakers

Mark Katz, MD
Course Director
Department of Urology
Boston Medical Center
Assistant Professor of Urology
Boston University School of Medicine
Boston, MA

David Hughes, PharmD, BCOP
Clinical Pharmacy Manager- Specialty Programs/Oncology
PGY2 Oncology Residency Program Director
Boston Medical Center
Department of Pharmacy
Boston University School of Medicine
Boston, MA

 

Planning Committee 

Mark Katz, MD
Course Director
Department of Urology
Boston Medical Center
Assistant Professor of Urology
Boston University School of Medicine
Boston, MA

David Hughes, PharmD, BCOP
Clinical Pharmacy Manager - Specialty Programs/Oncology
PGY2 Oncology Residency Program Director
Boston Medical Center
Department of Pharmacy
Boston University School of Medicine
Boston, MA

Alicia Katherine Morgans, MD, MPH
Genitourinary Medical Oncologist
Medical Director of Survivorship Program
Dana-Farber Cancer Institute
Boston, MA

Lynnette Henshaw, PharmD, BCOP
PGY2 Hematology/Oncology
Boston Medical Center
Boston, MA

Jasmine Patel, PharmD, BCOP
PGY2 Hematology/Oncology
Boston Medical Center
Boston, MA

 

Faculty Disclosures

David Hughes, PharmD, is a speaker for Abbvie and Amgen and receives grant support from Rigel Pharmaceuticals.

Dr. Alicia Morgans is a consultant and speaker for Astellas, AstraZeneca, Bayer, Clovis, Dendreon, Myovant, Lantheus, Merck, Sanofi, Janssen, Novartis and Pfizer. She also receives grant and research support from Astellas, Bayer, Dendreon and Seattle Genetics.

Jasmine Patel, PharmD receives grant support from Pfizer and is on the advisory board for Myovant.

Dr. Mark Katz and Lynette Henshaw, MD do not have anything to disclose. 

Physician Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and the ECHO Diabetes Action Network. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Nursing Accreditation

This educational activity has been provided by Boston University School of Medicine Continuing Nursing Education and jointly-provided by the ECHO Diabetes Action Network.

Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Contact Hours: 1.0 

 

ACPE Accreditation

The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This is an application-based educational activity. Pharmacists will receive 1.0 contact hours (0.10 CEUS) for the educational activity. No partial credit is available.

UNIVERAL ACTIVITY NUMBERS (UAN) 0060-9999-22-009-L01-P     

PROGRAM EVALUATION: Participants will have the opportunity to evaluate the educational session and speaker and to identify educational needs.

REQUIREMENTS FOR CE CREDIT

A program evaluation must be completed at www.uripharmacycpd.org within 60 days of the live program date in order to receive CE credit.  Please refer to the evaluation instructions that follow for completing program evaluations.

Instructions for Completing a Program Evaluation and Earning CPE credit (Pharmacists)

  1. Go to the University of Rhode Island College of Pharmacy Continuing Professional Development Learning Management System located at www.uripharmacycpd.org and create an account using your email address and professional license number.*  Enter all of the required account information.  Click the “Update Account” button at the bottom of the page to save the account information. 
  2. Complete the program evaluation.  Evaluations must be completed within 60 days of the program.
  • Log onto www.uripharmacycpd.org
  • Select Complete Live Activity Post-Test/Evaluations and select the program date and title of the activity (see below).
  • Enter the program evaluation code and complete program evaluation.
  • Select submit at the bottom of the page.
  • You will receive a confirmation message of evaluation completion and notification that your CE data was reported to the CPE Monitor.

Evaluation access code: GHC7

Available Credit

  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
    Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 ANCC
    Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
  • 1.00 Participation
Please login or register to take this course.